PeriNess
- Company typePrivate
- Founded2006
- HeadquartersRamat Gan, Israel
- Headcount1–10
- GTM typeB2C
- OfferingHardware or Manufacturing
PeriNess firmographics
Firmographics- Name
- PeriNess
- Website
- https://periness.com
- Company type
- Private
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Where PeriNess is headquartered
LocationHeadquarters
- HQ city
- Ramat Gan
- HQ country
- Israel
- HQ region
- Middle East
Markets served
PeriNess business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Marketing or Sales, Operations, Personnel
Go-to-market motion1 record
Marketing channels1 record
PeriNess product offering
Product offeringCore offering
PeriNess designs and markets Peri, a wearable device that tracks menopausal symptoms and monitors hormonal cycles for women in the menopause transition. The device supports at-home biomarker tracking and hormonal cycle monitoring, positioning it within the at-home health-monitoring category. The product was showcased at CES 2026 and is expected to ship in 2026, with some features still pending FDA approval.
Differentiator
Problem solved
Functional benefit
Brands
- Peri: Menopause tracking wearable device - a health and wellness technology product featuring biomarker tracking and hormonal cycle monitoring capabilities.
Products and services
- Peri Peri is a wearable device that monitors and tracks menopausal symptoms and biomarkers, enabling at-home hormonal cycle monitoring for women in the menopause transition.
Companies that use PeriNess
Customer profileSegments1 record
Ideal customer profiles1 record
PeriNess technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
PeriNess competitors and assessment
Company assessmentBroad incumbents
- Apple (Apple Watch): Apple Watch includes cycle tracking, temperature sensing (Series 8+), and FDA-cleared health features, positioning Apple as a broad incumbent with overlapping women's health functionality inside a general-purpose smartwatch.
- Fitbit (Google): Fitbit offers menstrual health tracking across its wearable lineup and has premium health subscription features. Broad incumbent competing in the same consumer wearable health monitoring category.
Direct peers
- Natural Cycles: Natural Cycles is an FDA-cleared fertility and cycle tracking platform that has expanded into perimenopause support. It is a direct competitor in hormonal cycle monitoring for women's health, though primarily app/thermometer-based rather than a dedicated wearable.
- Tempdrop: Tempdrop makes a wearable overnight temperature sensor for fertility and cycle tracking, including perimenopause use cases. Direct comparable as a purpose-built women's hormonal cycle wearable.
- Femometer (by iSnowbird): Femometer produces wearable basal body temperature thermometers and fertility/menopause tracking devices targeted at women's hormonal health — the closest hardware analog to Peri's proposition.
- Oura: Oura Ring is a consumer wearable that has progressively added women's cycle, fertility, and perimenopause tracking features. It is the most direct comparable as a premium consumer health wearable for hormonal and biomarker monitoring.
Emerging players
- Maven Clinic: Maven Clinic is a digital women's and family health platform with menopause care programs. Comparable as an emerging femtech incumbent in the broader women's health ecosystem serving overlapping customer needs.
- Carrot Fertility: Carrot provides employer-sponsored fertility, hormonal health, and menopause benefits. Comparable as an emerging femtech player intersecting with menopause care, though positioned as a benefits platform rather than a consumer device.
- Elektra Health: Elektra Health is a digital menopause care platform combining telehealth, education, and community. Comparable as an emerging player targeting the same menopause demographic with a service-led model.
- Clue: Clue is a leading period and cycle tracking app that has expanded into perimenopause content and modes. Comparable as an emerging women's health platform, though software-only rather than hardware.
Market position
Customer concentration
PeriNess social profiles
Digital presencePeriNess financial estimates
Financial estimateRevenue estimate
Valuation estimate
PeriNess leadership team
Management profileNumber of profiles
PeriNess funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PeriNess M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PeriNess
What does PeriNess do?
PeriNess designs and markets Peri, a wearable device that tracks menopausal symptoms and monitors hormonal cycles for women in the menopause transition. The device supports at-home biomarker tracking and hormonal cycle monitoring, positioning it within the at-home health-monitoring category. The product was showcased at CES 2026 and is expected to ship in 2026, with some features still pending FDA approval.
When was PeriNess founded?
PeriNess was founded in 2006. It employs 1 to 10 people.
Where is PeriNess based?
PeriNess is headquartered in Ramat Gan, Israel, in the Middle East region.
Who are PeriNess's main competitors?
Broad incumbents on record are Apple (Apple Watch) and Fitbit (Google). Direct peers are Natural Cycles, Tempdrop, Femometer (by iSnowbird) and Oura. Emerging players are Maven Clinic, Carrot Fertility, Elektra Health and Clue.
Does PeriNess have an API?
No public API is recorded for PeriNess.